Shapecaret-double-leftcaret-double-rightcaret-downcaret-leftcaret-right-circlecaret-rightShapeclosedropdownexpand morefacebookLogolinkedinlogo-footerlogo-marklogo-mobilemailsearchtwitteryoutube
Menu Close
project

FMX314; Fortimedix'single-site surgery solution


“Within laparoscopic surgery, also known as minimally invasive surgery, removing a gallbladder is one of the most common procedures,” Employeneur Frank Nijsten states. “At Fortimedix Surgical, we developed the first and only 15 millimeter single-site surgery solution, called the FMX314 platform, which consists of articulating instruments to achieve triangulation and an introducer device with four working channels to insert the instruments in the abdomen. Using this single-site surgery solution offers patients the potential for improved health outcomes, including fewer port-site complications, less post-operative pain, faster recovery and exceptional cosmesis. Moreover, the FMX314 offers surgeons the ability to comfortably perform single-site surgery in a manner closely mimicking traditional laparoscopy, enhancing ease of use and shortening learning curves.”

In July 2013, Frank Nijsten joined TMC Mechanical and started to work as a product development engineer for Fortimedix, mostly known as a global market leader in contract stent manufacturing. With a very diverse background in automotive, mechanical engineering, and healthcare, Frank fit the profile to work on the FMX314 project. According to Frank, “Fortimedix started on this project three years before I joined the team. First, I studied all medical documentation regarding the project to be fully informed about the instruments and models. Since I joined the project, I have contributed to the creative design and ease of use of the surgical instruments. I always find it challenging to search for ways to make a product easier to use.

At the end of this year, there will be a second clinical study in which the FMX314 will be tested, so in the coming months, we’re focusing on finalizing the product on a higher level. If this trial is successful yet again, the expectations are that the product will be produced and sold to hospitals by 2016. In the meantime, I’m enjoying this job, which offers me creativity and new technical knowledge and skills. I’m very proud of the results so far and honored to contribute innovative solutions to the medical industry. With the development of the FMX314, I believe we are really making a difference, and I’m looking forward to a successful introduction of the platform.”


With one test down, this prototype is considered successful. “At the end of this year, there will be a clinical study in which the FMX314 will be tested, so in the coming months, we’re focusing on finalizing the product on a higher level. If this trial is successful, the expectations are that the product will be produced and sold to hospitals by 2015. In the meantime, I’m enjoying this job, which offers me creativity and new technical knowledge and skills. Considering I’m the only product development engineer on this project, I’m very proud of the results so far and honored to contribute innovative solutions to the medical industry. With the development of the FMX314, I believe we are really making a difference, and I’m looking forward to a successful introduction of the instruments.”


What's your next step? We can help you with that